Indometacin Crescent Pharma

Indometacin, the active ingredient in Indometacin Crescent Pharma, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to reduce inflammation and pain in conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout flares, and acute musculoskeletal pain.

GNH USA supplies Indometacin Crescent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics across global distribution.

Indometacin is indicated for several inflammatory and musculoskeletal disorders, acting primarily to control pain and swelling. - Rheumatoid arthritis: reduces joint inflammation and pain, helping maintain function. - Osteoarthritis: alleviates chronic joint pain and stiffness associated with degenerative changes. - Ankylosing spondylitis: diminishes spinal inflammation and discomfort, improving mobility. - Gout flares: provides rapid relief of acute gouty arthritis pain and swelling. - Acute musculoskeletal pain: lessens pain and inflammation in injuries or overuse conditions.

Indometacin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dyspepsia or stomach upset. - Headache. - Dizziness or vertigo. - Skin rash or mild itching.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding. - Acute renal failure or worsening kidney function. - Severe hepatic injury or hepatitis. - Life‑threatening skin reactions such as Stevens‑Johnson syndrome or anaphylaxis.

When prescribing Indometacin, clinicians should consider several safety measures. - Renal function: monitor in patients with existing kidney disease. - Gastrointestinal risk: use the lowest effective dose and consider gastroprotective agents. - Cardiovascular: avoid in patients with uncontrolled hypertension or heart failure. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Drug interactions: review concomitant NSAIDs, anticoagulants, and antihypertensives. - Store at below 25°C: keep in the original container, protect from moisture and light.

Indometacin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Lithium: elevated lithium serum concentrations. - Methotrexate: enhanced toxicity and reduced clearance.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible decline in renal function. - Diuretics: heightened risk of renal impairment. - Corticosteroids: increased likelihood of gastrointestinal ulceration.